Back to trial detailsIntake questionnaire
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Applying to Asheville Clinical Research · Asheville, North Carolina
Answer a few short questions to share with the research team.
0 of 4 answered